Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 867
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
for
Metastatic Small Intestinal Adenocarcinoma,
Location: Denver CO, Thornton CO, Wheat Ridge CO, Golden CO,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04205968
Phase2, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Denver CO, Golden CO, Grand Junction CO, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Denver CO, Lone Tree CO, Lafayette CO, Edwards CO,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT06931340
Phase3, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Location: Denver CO, Salt Lake City UT, Dallas TX, Austin TX,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06586957
Phase1, Recruiting
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
for
HER2 Expressing Solid Tumors
Location: Denver CO, Rochester MN, Los Angeles CA, Houston TX,
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT07192432
Phase1, Phase2, Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation